A platform built with surgeons, for surgeons.

EndoChor® was founded in Istanbul to close the gap between the elegance of endoscopic facial surgery and the hardware surgeons had available for soft-tissue fixation. Every device in the family is built from the same 82/18 L-lactide/Glycolide Co-Polymer and shares one dedicated instrument set.

The platform is powered by Multi-Vectoral Technology (MVT), which distributes tension across every tine for monoblock lifting and biological fixation. Implants retain 70% of their initial strength for the first three months and fully resorb within approximately 24 months.

EndoChor® is CE-certified as a Class III medical device and used in leading aesthetic and reconstructive centers across Europe, the Middle East and Asia.